HomeCompareBEST vs PFE

BEST vs PFE: Dividend Comparison 2026

BEST yields 71.94% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BEST wins by $1.10M in total portfolio value
10 years
BEST
BEST
● Live price
71.94%
Share price
$2.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.15M
Annual income
$308,123.11
Full BEST calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BEST vs PFE

📍 BEST pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBESTPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BEST + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BEST pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BEST
Annual income on $10K today (after 15% tax)
$6,115.11/yr
After 10yr DRIP, annual income (after tax)
$261,904.64/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, BEST beats the other by $239,584.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BEST + PFE for your $10,000?

BEST: 50%PFE: 50%
100% PFE50/50100% BEST
Portfolio after 10yr
$600.1K
Annual income
$167,190.91/yr
Blended yield
27.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BEST
Analyst Ratings
3
Buy
4
Hold
Consensus: Hold
Price Target
$8.00
+187.8% upside vs current
Range: $8.00 — $8.00
Altman Z
-4.0
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BEST buys
0
PFE buys
0
No recent congressional trades found for BEST or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBESTPFE
Forward yield71.94%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$1.15M$49.6K
Annual income after 10y$308,123.11$26,258.71
Total dividends collected$984.4K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold
Analyst price target$8.00$27.50

Year-by-year: BEST vs PFE ($10,000, DRIP)

YearBEST PortfolioBEST Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$17,894$7,194.24$9,153$693.39+$8.7KBEST
2$31,178$12,031.36$8,593$849.25+$22.6KBEST
3$52,952$19,591.55$8,336$1,066.78+$44.6KBEST
4$87,756$31,096.97$8,437$1,384.80+$79.3KBEST
5$142,063$48,164.40$9,013$1,875.40+$133.1KBEST
6$224,877$72,869.84$10,306$2,680.72+$214.6KBEST
7$348,421$107,802.39$12,820$4,101.38+$335.6KBEST
8$528,911$156,100.17$17,673$6,826.70+$511.2KBEST
9$787,396$221,461.11$27,543$12,591.86+$759.9KBEST
10$1,150,637$308,123.11$49,560$26,258.71+$1.10MBEST

BEST vs PFE: Complete Analysis 2026

BESTStock

BEST Inc. operates as a smart supply chain service provider in the People's Republic of China. Its proprietary technology platform, BEST Cloud, enables its ecosystem participants to operate their businesses through various SaaS-based applications. The company applies its technologies to a range of applications, such as network and route optimization, swap bodies, sorting line automation, smart warehouses, and store management. In addition, the company offers integrated services and solutions across the supply chain, including warehouse management, order fulfillment, and transportation services to offline and online enterprises. Further, the company provides express delivery services; and door-to-door integrated cross-border supply chain services to and from China, including international express, less-than-truckload, fulfillment, and freight forwarding through its network, and transportation and warehouse partners. Additionally, the company operates real-time bidding platform to source truckload capacity from independent transportation service providers and agents; and offers online merchandise sourcing and store management services for convenience stores, as well as B2C services. Furthermore, it provides various value-added services, including customized financial services, including fleet and equipment leases; and centralized sourcing of products and services, such as bulk procurement of trucks and accessories. The company was founded in 2007 and is headquartered in Hangzhou, the People's Republic of China.

Full BEST Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BEST vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BEST vs SCHDBEST vs JEPIBEST vs OBEST vs KOBEST vs MAINBEST vs JNJBEST vs MRKBEST vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.